Protective effects of estrogen and selective estrogen receptor modulators in the brain

Biology of Reproduction

Volumn 67, Issue 5, 2002, Pages 1379-1385

  Dhandapani, Krishnan M ^a   Brann, Darrell W ^a  

^a Institute of Molecular Medicine and Genetics   (United States)

Author keywords

Estradiol; Neuroendocrinology; Steroid hormones

Indexed keywords

ANTIOXIDANT; ARZOXIFENE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SCAVENGER; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; NEUROPROTECTIVE AGENT; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ASTROCYTE; CEREBROVASCULAR ACCIDENT; DEGENERATIVE DISEASE; DRUG MECHANISM; ENZYME ACTIVATION; ESTROGEN THERAPY; GENETIC TRANSCRIPTION; HUMAN; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SHORT SURVEY; ANIMAL; BRAIN; DRUG EFFECT; GENETICS; METABOLISM; PHYSIOLOGY; REVIEW;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIOXIDANTS; BRAIN; ENZYME ACTIVATION; ESTRADIOL; ESTROGENS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NEUROPROTECTIVE AGENTS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 0036838768     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.102.003848     Document Type: Short Survey

References (81)

1. Simpkins JW, Rajakumar G, Zhang YQ, Simpkins CE, Greenwald D, Yu CJ, Bodor N, Day AL. Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J Neurosurg 1997; 87:724-730.
2. Alkayed NJ, Harukuni I, Kimes AS, London ED, Traystman RJ, Hurn PD. Gender-linked brain injury in experimental stroke. Stroke 1998; 29:159-166.
3. Dubal DB, Kashon ML, Pettigrew LC, Ren JM, Finklestein SP, Rau SW, Wise PM. Estradiol protects against ischemic injury. J Cereb Blood Flow Metab 1998; 18:1253-1258.
4. Shi J, Panickar KS, Yang SH, Rabbani O, Day AL, Simpkins JW. Estrogen attenuates over-expression of β-amyloid precursor protein messenger RNA in an animal model of focal ischemia. Brain Res 1998; 810:87-92.
5. Zhang YQ, Shi J, Rajakumar G, Day AL, Simpkins JW. Effects of gender and estradiol treatment on focal brain ischemia. Brain Res 1998; 784:321-324.
6. Rusa R, Alkayed NJ, Crain BJ, Traystman RJ, Kimes AS, London ED, Klaus JA, Hurn PD. 17β-estradiol reduces stroke injury in estrogen-deficient animals. Stroke 1999; 30:1665-1670.
7. Toung TJK, Traystman RJ, Hurn PD. Estrogen-mediated neuroprotection after experimental stroke in males. Stroke 1998; 29:1666-1670.
8. Alkayed NJ, Murphy SJ, Traystman RJ, Hurn PD. Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. Stroke 2000; 31:161-168.
9. Hall ED, Pazara KE, Linseman KL. Sex differences in postischemic neuronal necrosis in gerbils. J Cereb Blood Flow Metab 1991; 11: 292-298.
10. Alkayed NJ, Crain BJ, Traystman RJ, Hurn PD. Estrogen-mediated neuroprotection in reproductively senescent rats. Stroke 1999; 30:274.
11. Dubal DB, Wise PM. Neuroprotective effects of estradiol in middle-aged female rats. Endocrinology 2001; 142:43-48.
12. Murphy SJ, Traystman RJ, Hurn PD, Duckles SP. Progesterone exacerbates striatal stroke injury in progesterone-deficient female animals. Stroke 2000; 31:1173-1178.
13. Liao SL, Chen WY, Kuo JS, Chen CJ. Association of serum estrogen level and ischemic neuroprotection in female rats. Neurosci Lett 2001; 297:159-162.
14. Sawada M, Alkayed NJ, Goto S, Crain BJ, Traystman RJ, Shaivitz A, Nelson RJ, Hurn PD. Estrogen receptor antagonist ICI182,780 exacerbates ischemic injury in female mouse. Stroke 2000;20:112-118.
15. Diaz-Brinton R, Chen S, Montoya M, Hseih D, Minaya J, Kim J, Chu HP. The women's health initiative estrogen replacement therapy is neurotrophic and neuroprotective. Neurobiol Aging 2000; 21:475-496.
16. Brinton RD, Chen S, Montoya M, Hsieh D, Minaya J. The estrogen replacement therapy of the women's health initiative promotes the cellular mechanisms of memory and neuronal survival in neurons vulnerable to Alzheimer's disease. Maturitas 2000; 34(suppl 2):S35-S52.
17. Rossberg MI, Murphy SJ, Traystman RJ, Hurn PD. LY353381.HCl, a selective estrogen receptor modulator, and experimental stroke. Stroke 2000; 31:3041-3046.
18. Kimelberg HK, Feustel PJ, Jin Y, Paquette J, Boulos A, Keller RW Jr, Tranmer BI. Acute treatment with tamoxifen reduces ischemic damage following middle cerebral artery occlusion. Neuroreport 2000; 11:2675-2679.
19. Mehta SH, Dhandapani KM, Webb RC, Mahesh VB, Brann DW. Therapeutic doses of tamoxifen exert neuroprotective effects in acute ischemic stroke. Soc Neurosci Abstr 2001; 27:437.11.
20. Osuka K, Feustel PJ, Mongin AA, Tranmer BI, Kimelberg HK. Tamoxifen inhibits nitrotyrosine formation after reversible middle cerebral artery occlusion in the rat. J Neurochem 2001; 76:1842-1850.
21. Obata T, Kubota S. Protective effect of tamoxifen on 1-methyl-4-phenylpyridine-induced hydroxyl radical generation in the rat striatum. Neurosci Lett 2001; 308:87-90.
22. Silva I, Mello LE, Freymuller E, Haidar MA, Baracat EC. Estrogen, progestogen, and tamoxifen increase synaptic density of the hippocampus of ovariectomized rats. Neurosci Lett 2000; 291:183-186.
23. Nilsen J, Mor G, Naftolin F. Raloxifene induces neurite outgrowth in estrogen receptor positive PCl2 cells. Menopause 1998; 5:211-216.
24. Singer CA, Rogers KL, Strickland TM, Dorsa DM. Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci Lett 1996; 212:13-16.
25. Wilson ME, Dubal DB, Wise PM. Estradiol protects against injury-induced cell death in cortical explant cultures: a role for estrogen receptors. Brain Res 2000; 873:235-242.
26. Dubal DB, Shughrue PJ, Wilson ME, Merchenthaler I, Wise PM. Estradiol modulates bcl-2 in cerebral ischemia: A potential role for estrogen receptors. J Neurosci 1999; 19:6385-6393.
27. Singer CA, Rogers KL, Dorsa DM. Modulation of Bcl-2 expression: A potential component of estrogen protection in NT2 neurons. Neuroreport 1998; 9:2565-2568.
28. Alkayed NJ, Goto S, Sugo N, Joh HD, Klaus J, Crain BJ, Bernard O, Traystman RJ, Hurn PD. Estrogen and Bcl-2: Gene induction and effect of transgene in experimental stroke. J Neurosci 2001; 21:7543-7550.
29. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A 1996; 93:5925-5930.
30. Treuter E, Warner M, Gustafsson JA. Mechanism of oestrogen signalling with particular reference to the role of ER beta in the central nervous system. Novartis Found Symp 2000; 230:7-14.
31. Dubal DB, Zhu H, Yu J, Rau SW, Shughrue PJ, Merchenthaler I, Kindy MS, Wise PM. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci U S A 2001; 98:1952-1957.
32. Sampei K, Goto S, Alkayed NJ, Crain BJ, Korach KS, Traystman RJ, Demas GE, Nelson RJ, Hurd PD. Stroke in estrogen receptor-α-deficient mice. Stroke 2000; 31:738-744.
33. Couse JF, Curtis SW, Washburn TF, Lindzey J, Golding TS, Lubahn DB, Smithies O, Korach KS. Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol Endocrinol 1995; 9:1441-1454.
34. Wang L, Andersson S, Warner M, Gustafsson JA. Morphological abnormalities in the brains of estrogen receptor beta knockout mice. Proc Natl Acad Sci U S A 2001; 98:2792-2796.
35. Kuroki Y, Fukushima K, Kanda Y, Mizuno K, Watanabe Y. Neuroprotection by estrogen via extracellular signal-regulated kinase against quinolinic acid-induced cell death in the rat hippocampus. Eur J Neurosci 2001; 13:472-476.
36. Han BH, Holtzman DM. BDNF protects the neonatal brain from hypoxia-ischemia injury in vivo via the ERK pathway. J Neurosci 2000; 20:5775-5781.
37. Philpott KL, McCarthy MJ, Klippel A, Rubin LL. Activated phosphatidylinositol 3-kinase and Akt kinase promote survival or superior cervical neurons. J Cell Biol 1997; 139:809-815.
38. Eves EM, Xiong W, Bellacosa A, Kennedy SG, Tsichlis PN, Rosner MR, Hay N. Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line. Mol Cell Biol 1998; 18:2143-2152.
39. Crowder RJ, Freeman RS. Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. J Neurosci 1998; 18: 2933-2943.
40. Singer CA, Figueroa-Masot XA, Batchelor RH, Dorsa DM, The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 1999; 19:2455-2463.
41. Singh M, Setalo G Jr, Guan X, Warren M, Toran-Allerand CD, Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: Convergence of estrogen and neurotrophin signaling pathways. J Neurosci 1999; 19:1179-1186.
42. Singh M, Setalo G Jr, Guan X, Frail DE, Toran-Allerand CD. Estrogen-induced activation of the mitogen-activation protein kinase cascade in the cerebral cortex of estrogen receptor-α knock-out mice. J Neurosci 2000; 20:1694-1700.
43. Singh M. Ovarian hormones elicit phosphorylation of Akt and extracellular signal regulated kinase in explants of the cerebral cortex. Endocrine 2001; 14:407-415.
44. Bi R, Broutman G, Foy MR, Thompson RF, Baudry M. The tyrosine kinase and mitogen-activated protein kinase pathways mediate multiple effects of estrogen in hippocampus. Proc Natl Acad Sci U S A 2000; 97:3602-3607.
45. Bi R, Foy MR, Vouimba RM, Thompson RF, Baudry M. Cyclic changes in estradiol regulate synaptic plasticity through the MAP kinase pathway. Proc Natl Acad Sci U S A 2001; 98:13391-13395.
46. Brunet A, Datta SR, Greenberg ME. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 2001; 11:297-305.
47. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. Akt phosphorylation of BAD couples survival signals to the cellintrinsic death machinery. Cell 1997; 91:231-241.
48. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995; 378:785-789.
49. Honda K, Sawada H, Kihara T, Urushitani M, Nakamizo T, Akaike A, Shimohama S. Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons. J Neurosci Res 2000; 60:321-327.
50. Honda K, Shimohama S, Sawada H, Kihara T, Nakamizo T, Shibasaki H, Akaike A. Nongenomic antiapoptotic signal transduction by estrogen in cultured cortical neurons. J Neurosci Res 2001; 64:466-475.
51. Zhang L, Rubinow DR, Xaing G, Li BS, Chang YH, Maric D, Barker JL, Ma W. Estrogen protects against beta-amyloid-induced neurotoxicity in rat hippocampal neurons by activation of Akt. Neuroreport 2001; 12:1919-1923.
52. Hisamoto K, Ohmichi M, Kanda Y, Adachi K, Nishio Y, Hayakawa J, Mabuchi S, Takahashi K, Tasaka K, Miyamoto Y, Taniguchi N, Murata Y. Induction of endothelial nitric-oxide synthase phosphorylation by the raloxifene analog LY117018 is differentially mediated by Akt and extracellular signal-regulated protein kinase in vascular endothelial cells. J Biol Chem 2001; 276:47642-47649.
53. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 2000; 407:538-541.
54. Kim HP, Lee JY, Jeong JK, Bae SW, Lee HK, Jo I. Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor alpha localized in caveolae. Biochem Biophys Res Commun 1999; 263:257-262.
55. Monje P, Zanello S, Holick M, Boland R. Differential cellular localization of estrogen receptor alpha in uterine and mammary cells. Mol Cell Endocrinol 2001; 181:117-129.
56. Moosmann B, Behl C. The antioxidant neuroprotective effect of estrogens and phenolic compounds are independent from their estrogenic properties. Proc Natl Acad Sci U S A 1999; 96:8867-8872.
57. Behl C, Widmann M, Trapp T, Holsboer F. 17β-estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 1995; 216:473-482.
58. Behl C, Skutella T, Lezoualc'h F, Post A, Widmann M, Newton CJ, Holsboer F. Neuroprotection against oxidative stress by estrogen: Structure-activity relationship. Mol Pharmacol 1997; 51:535-541.
59. Blum-Degen D, Haas M, Pohli S, Harth R, Romer W, Oettel M, Riederer P, Gotz ME. Scavestrogens protect IMR 32 cells from oxidative stress-induced cell death. Toxicol Appl Pharmacol 1998; 152:49-55.
60. Goodman Y, Bruce AJ, Cheng B, Mattson MP. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons. J Neurochem 1996; 66:1836-1844.
61. Bae YH, Hwang JY, Kim YH, Koh JY. Anti-oxidative neuroprotection by estrogens in mouse cortical cultures. J Korean Med Sci 2000; 15: 327-336.
62. Green PS, Gridley KE, Simpkins JW. Estradiol protects β-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci Lett 1996; 218:165-168.
63. Mook-Jung I, Joo I, Sohn S, Kwon HJ, Huh K, Jung MW. Estrogen blocks neurotoxic effects of beta-amyloid (1-42) and induces neurite extension on B103 cells. Neurosci Lett 1997; 235:101-104.
64. Lacort M, Leal AM, Liza M, Martin C, Martinez R, Ruiz-Larrea B. Protective effect of estrogens and catecholestrogens against peroxidative membrane damage in vitro, Lipids 1995; 30:141-146.
65. Vedder H, Anthes N, Stumm G, Wurz C, Behl C, Krieg JC. Estrogen hormones reduce lipid peroxidation in cells and tissues of the central nervous system. J Neurochem 1999; 72:2531-2538.
66. Cardona-Gomez GP, Mendez P, DonCarlos LL, Azcoitia I, Garcia-Segura LM. Interactions of estrogens and insulin-like growth factor-I in the brain: Implications for neuroprotection. Brain Res Rev 2001; 37:320-334.
67. Cui W, Allen ND, Skynner M, Gusterson B, Clark AJ. Inducible ablation of astrocytes shows that these cells are required for neuronal survival in the adult brain. Glia 2001; 34:272-282.
68. Dhandapani KM, Wade FM, Buchanan CD, Brann DW. Transforming growth factor-β released by astrocytes enhances connectivity and survival of neurons: regulation by 17β-estradiol. In: Program of the annual meeting of the American Society for Cell Biology; 2000; San Francisco, CA. Abstract 141.
69. D'Onofrio M, Cuomo L, Battaglia G, Ngomba RT, Storto M, Kingston AE, Orzi F, De Blasi A, Di Iorio O, Nicoletti F, Bruno V. Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways. J Neurochem 2001; 78:435-445.
70. Wang XF, Cynader MS. Pyruvate released by astrocytes protects neurons from copper-catalyzed cysteine neurotoxicity. J Neurosci 2001; 21:3322-3331.
71. Lamigeon C, Bellier JP, Sacchettoni S, Rujano M, Jacquemont B. Enhanced neuronal protection from oxidative stress by coculture with glutamic acid decarboxylase-expressing astrocytes. J Neurochem 2001; 77:598-606.
72. Hosli E, Ruhl W, Hosli L. Histochemical and electrophysiological evidence for estrogen receptors on cultured astrocytes: Colocalized with cholinergic receptors. Int J Dev Neurosci 2000; 18:101-111.
73. Hosli E, Jurasin K, Ruhl W, Luthy R, Hosli L. Colocalization of androgen, estrogen, and cholinergic receptors on cultured astrocytes of rat central nervous system. Int J Dev Neurosci 2001; 19:11-19.
74. Buchanan CD, Mahesh VB, Brann DW. Estrogen-astrocyte-luteinizing hormone-releasing hormone signaling: A role for transforming growth factor-beta 1. Biol Reprod 2000; 62:1710-1721.
75. Azcoitia I, Sierra A, Garcia-Segura LM. Localization of estrogen receptor-β immunoreactivity in astrocytes of the adult rat brain. Glia 1999; 26:260-267.
76. Santagati S, Melcangi RC, Celotti F, Martini L, Maggi A. Estrogen receptor is expressed in different types of glial cells in culture. J Neurochem 1994; 63:2058-2064.
77. Bruno V, Battaglia G, Casabona G, Copani A, Caciagli F, Nicoletti F. Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta. J Neurosci 1998; 18:9594-9600.
78. Prehn JH, Bindokas VP, Marcuccilli CJ, Krajewski S, Reed JC, Miller RJ. Regulation of neuronal Bcl-2 protein expression and calcium homeostasis by transforming growth factor beta confers wide-ranging protection on rat hippocampal neurons. Proc Natl Acad Sci U S A 1994; 91:12599-12603.
79. Prehn JH, Bindokas VP, Jordan J, Galindo MF, Ghadge GD, Roos RP, Boise LH, Thompson CB, Krajewski S, Reed JC, Miller RJ. Protective effect of transforming growth factor betal on beta-amyloid neurotoxicity in rat hippocampal neurons. Mol Pharmacol 1996; 49:319-328.
80. Ren RF, Flanders KC. Transforming growth factor beta protects primary rat hippocampal neuronal cultures from degeneration induced by beta-amyloid peptide. Brain Res 1996; 732:16-24.
81. Ren RF, Hawver DB, Kim RS, Flanders KC. Transforming growth factor beta protects human hNT cells from degeneration induced by beta-amyloid peptide: Involvement of the TGF-beta type II receptor. Brain Res Mol Brain Res 1997; 48:315-322.